198 GSK Annual Report 2017 Notes to the financial statements continued 29.
Other provisions Legal Major Employee and other restructuring related Other disputes programmes provisions provisions Total m m m m m At 1 January 2017 344 554 306 296 1,500 Exchange adjustments 29 16 8 6 59 Charge for the year 173 259 50 69 551 Reversed unused 7 43 3 36 89 Unwinding of discount 2 4 10 16 Utilised 288 233 41 67 629 Reclassifications and other movements 9 3 5 7 Transfer to Pension obligations 18 18 At 31 December 2017 186 504 304 271 1,265 To be settled within one year 138 292 90 109 629 To be settled after one year 48 212 214 162 636 At 31 December 2017 186 504 304 271 1,265 The Pharmaceuticals restructuring programme, announced in Legal and other disputes October 2014, has been focused on rescaling commercial The Group is involved in a substantial number of legal and other operations, global support functions and certain R&D manufacturing disputes, including notification of possible claims, as set out in operations across Pharmaceuticals.
In addition, an integration Note 45 Legal proceedings.
Provisions for legal and other disputes include amounts relating to product liability, anti-trust, government restructuring programme was initiated in 2015, following the investigations, contract terminations, self insurance and completion of the Novartis transaction, and the CEO Strategic environmental clean-up.
Initiatives Programme was announced in July 2017.
All of these restructuring and integration programmes are now reported together The charge for the year of 166 million net of reversals and as one combined major restructuring programme.
estimated insurance recoveries primarily related to provisions for product liability cases regarding Paxil and other products, Provisions for staff severance payments are made when management commercial disputes and various other government investigations.
has made a formal decision to eliminate certain positions and this has been communicated to the groups of employees affected and The discount on the provisions increased by 2 million in 2017 appropriate consultation procedures completed, where appropriate.
The discount was calculated No provision is made for staff severance payments that are made using risk-adjusted projected cash flows and risk-free rates of return.
In respect of product liability claims related to certain products, Pension augmentations arising from staff redundancies of there is sufficient history of claims made and settlements to enable 18 million 2016 23 million have been charged during the management to make a reliable estimate of the provision required to year and then transferred to the pension obligations provision as cover unasserted claims.
The ultimate liability for such matters may shown in Note 28, Pensions and other post-employment benefits.
vary from the amounts provided and is dependent upon the outcome Asset write-downs have been recognised as impairments of of litigation proceedings, investigations and possible settlement property, plant and equipment in Note 17, Property, plant and negotiations.
The majority of the amounts provided are expected It is in the nature of the Groups business that a number of these to be utilised in the next two years.
matters may be the subject of negotiation and litigation over Employee related provisions many years.
Litigation proceedings, including the various appeal Employee related provisions include obligations for certain medical procedures, often take many years to reach resolution, and benefits to disabled employees and their spouses in the US.
At out-of-court settlement discussions can also often be protracted.
31 December 2017, the provision for these benefits amounted to The Group is in potential settlement discussions in a number of 108 million 2016 135 million.
Other employee benefits reflect the disputes for which amounts have been provided and, based a variety of provisions for severance costs, jubilee awards and other on its current assessment of the progress of these disputes, long-service benefits.
estimates that 138 million of the amount provided at 31 December Other provisions 2017 will be settled within one year.
At 31 December 2017, it was Included in other provisions are insurance provisions of 6 million expected that nil million 2016 nil of the provision made for legal 2016 40 million, onerous property lease provisions of and other disputes will be reimbursed by third party insurers.
For a 38 million 2016 39 million and a number of other provisions discussion of legal issues, see Note 45, Legal proceedings.
including vehicle insurance and regulatory matters.
Major restructuring programmes In 2013, the Group initiated the Major Change restructuring programme focused on opportunities to simplify supply chain processes, build the Groups capabilities in manufacturing and R&D and restructure the European Pharmaceuticals business.
